Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Pharmacogenomics: co-designing a community pharmacy testing service in England
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: CPS-078
- By: RENDELL, Tim (University of Bath, United Kingdom)
- Co-author(s): Mr Tim Rendell (University of Bath, United Kingdom)
Professor Julie Barnett, Department of Psychology (University of Bath, United Kingdom)
Professor David Wright, School of Allied Health Professions (University of Leicester, United Kingdom)
Dr Sion Scott, University of Leicester (University of Leicester, United Kingdom)
Pharmacogenomics (PGx) is the use of Deoxyribonucleic Acid (DNA) to predict an individuals’ response to a drug. Through the lower cost of DNA sequencing and advances in genomic medicine, PGx testing is a viable and valuable tool in improving medicines optimisation for patients.
Over recent years, the role of the community pharmacist in.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019